Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
18.44
-1.49 (-7.48%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Caris Life Sciences Market Cap
Caris Life Sciences has a market cap or net worth of $5.21 billion as of April 28, 2026.
Market Cap
5.21B
Enterprise Value
4.84B
1-Year Change
n/a
Ranking
Category
Stock Price
$18.44
Market Cap Chart
Since the IPO on June 18, 2025, Caris Life Sciences's market cap has decreased from $5.95B to $5.21B, a decrease of -12.47%. That is a compound annual growth rate of -14.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 5.63B | -26.00% |
| Dec 31, 2025 | 7.61B | 27.84% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Centessa Pharmaceuticals | 6.10B |
| Spyre Therapeutics | 6.01B |
| Cogent Biosciences | 5.93B |
| Rhythm Pharmaceuticals | 5.85B |
| Celcuity | 5.85B |
| Immunovant | 5.82B |
| CG Oncology | 5.80B |
| PTC Therapeutics | 5.66B |